2024/646

14.3.2024

DECISION OF THE EEA JOINT COMMITTEE No 342/2021

of 10 December 2021

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/646]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2021/726 of 4 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances Adoxophyes orana granulovirus and flutriafol ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distilation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/ sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2021/795 of 17 May 2021 withdrawing the approval of the active substance alpha-cypermethrin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2021/809 of 20 May 2021 concerning the non-approval of fermented extract from leaves of Symphytum officinale L. (comfrey) as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Regulation (EU) 2021/843 of 26 May 2021 renewing the approval of the active substance cyazofamid, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Regulation (EU) 2021/853 of 27 May 2021 renewing the approval of the active substance Streptomyces strain K61 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 7 ) is to be incorporated into the EEA Agreement.

(8) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘-

32021 R 0726 : Commission Implementing Regulation (EU) 2021/726 of 4 May 2021 ( OJ L 155, 5.5.2021, p. 20 ),

- 32021 R 0745 : Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 ( OJ L 160, 7.5.2021, p. 89 ),

- 32021 R 0795 : Commission Implementing Regulation (EU) 2021/795 of 17 May 2021 ( OJ L 174, 18.5.2021, p. 2 ),

- 32021 R 0824 : Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 ( OJ L 183, 25.5.2021, p. 35 ),

- 32021 R 0843 : Commission Implementing Regulation (EU) 2021/843 of 26 May 2021 ( OJ L 186, 27.5.2021, p. 20 ),

- 32021 R 0853 : Commission Implementing Regulation (EU) 2021/853 of 27 May 2021 ( OJ L 188, 28.5.2021, p. 56 ).’

The following is added in point 13w (Commission Implementing Regulation (EU) No 820/2011):

‘, as amended by:

— 32021 R 0824 : Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 ( OJ L 183, 25.5.2021, p. 35 ).’

The following points are inserted after point 13zzzzzzzzzzzs (Commission Implementing Regulation (EU) 2021/567):

‘13zzzzzzzzzzzt.

32021 R 0795 : Commission Implementing Regulation (EU) 2021/795 of 17 May 2021 withdrawing the approval of the active substance alpha-cypermethrin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L 174, 18.5.2021, p. 2 ).

13zzzzzzzzzzzu.

32021 R 0809 : Commission Implementing Regulation (EU) 2021/809 of 20 May 2021 concerning the non-approval of fermented extract from leaves of Symphytum officinale L. (comfrey) as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market ( OJ L 180, 21.5.2021, p. 110 ).

13zzzzzzzzzzzv.

32021 R 0824 : Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine ( OJ L 183, 25.5.2021, p. 35 ).

13zzzzzzzzzzzw.

32021 R 0843 : Commission Implementing Regulation (EU) 2021/843 of 26 May 2021 renewing the approval of the active substance cyazofamid, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( OJ L 186, 27.5.2021, p. 20 ).

13zzzzzzzzzzzx.

32021 R 0853 : Commission Implementing Regulation (EU) 2021/853 of 27 May 2021 renewing the approval of the active substance Streptomyces strain K61 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 ( OJ L 188, 28.5.2021, p. 56 ).’

Article 2

The texts of Implementing Regulations (EU) 2021/726, (EU) 2021/745, (EU) 2021/795, (EU) 2021/809, (EU) 2021/824, (EU) 2021/843 and (EU) 2021/853 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 11 December 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 10 December 2021.

For the EEA Joint Committee

The President

Rolf Einar FIFE

( 1 ) OJ L 155, 5.5.2021, p. 20 .

( 2 ) OJ L 160, 7.5.2021, p. 89 .

( 3 ) OJ L 174, 18.5.2021, p. 2 .

( 4 ) OJ L 180, 21.5.2021, p. 110 .

( 5 ) OJ L 183, 25.5.2021, p. 35 .

( 6 ) OJ L 186, 27.5.2021, p. 20 .

( 7 ) OJ L 188, 28.5.2021, p. 56 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/646/oj

ISSN 1977-0677 (electronic edition)